Pan-cancer analysis of ACHE as a biomarker forcancer prognosis and immunotherapy. Genetics and Molecular Research, [S. l.], v. 24, n. 1, p. 1–17, 2025. DOI: 10.4238/z2qb9g57. Disponível em: https://geneticsmr.com/index.php/gmr/article/view/111.. Acesso em: 14 sep. 2025.